Abstract
Cerebral radiation necrosis (CRN) is a serious complication of radiotherapy for intracranial tumors and skull base tumors. Since there lacked effective therapeutic methods in the past, CRN was once considered to be progressive and irreversible. With the development of histopathology and neuroimaging, the development and progression of CRN is gradually clarified, and new therapeutic methods have been developed. In recent years, the scholars at home and abroad have tried to use bevacizumab (a humanized monoclonal antibody targeting vascular endothelial growth factor), nerve growth factor, and ganglioside in the treatment of CRN and have achieved definite therapeutic effects. In some patients, cerebral necrosis was even repaired and reversed. This article reviews the incidence, pathophysiology, treatment, and prognosis of CRN. Key words: Radiation cerebral necrosis; New knowledge; Prevention and cure
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
